Brief: Cytokinetics Supports American Heart Association Initiative To Improve Care For People Living With Hypertrophic Cardiomyopathy
17/11/2025 13:14
Cytokinetics Inc CYTK.O: CYTOKINETICS SUPPORTS AMERICAN HEART ASSOCIATION INITIATIVE TO IMPROVE CARE FOR PEOPLE LIVING WITH HYPERTROPHIC CARDIOMYOPATHY Source text: ID:nGNX52VbLL Further company coverage: CYTK.O
Recent news on Cytokinetics, Incorporated
See all newsBrief: Cytokinetics To Announce Third Quarter Results On November 4, 2026
Brief: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Cytokinetics Announces Additional Data From Acacia-Hcm Presented At The Hfsa Annual Scientific Meeting 2026
Brief: Cytokinetics Launches Aspen-Hcm A Real-World Study Evaluating Myqorzo® (Aficamten) In Symptomatic Obstructive Hypertrophic Cardiomyopathy
U.S. STOCKS ON THE MOVE-Bleichroeder Acquisition Corp, Halliburton, BioNTech